| Adrianne N Noboa, CRNA | |
|
12511 World Plaza Ln, Building 50, Fort Myers, FL 33907-3991 | |
| (239) 939-2622 | |
| (239) 939-0151 |
| Full Name | Adrianne N Noboa |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 11 Years |
| Location | 12511 World Plaza Ln, Fort Myers, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023440740 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | APN18454 (Tennessee) | Secondary |
| 367500000X | Nurse Anesthetist, Certified Registered | ARNP9273490 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Naples Community Hospital | Naples, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anesthesia And Pain Consultants Of Sw Fl | 4082507835 | 74 |
| Gulf-to-bay Anesthesiology Associates Llc | 5092628156 | 363 |
| Nchmd Inc | 9436139565 | 374 |
News Archive
Bioject Medical Technologies Inc. (OTCBB:BJCT), a leading developer of needle-free injection therapy systems, today announced that it has established a strategic alliance with MPI Research, a leading pre-clinical research organization with experience in the development of injectable therapeutics.
"Long second shrift to other medical training, nursing education has taken on new relevance as the country faces a drastic shortage of nurses and a thin job market overall," The Dallas Morning News reports.
The fight against the deadly tropical disease Leishmaniasis, also known as black fever, has been boosted by scientists at the University of Durham, whose new screening system has raised the possibility of new, safer drugs.
Onyx Pharmaceuticals, Inc. today announced its plans to expand the Phase 3 European clinical trial FOCUS, which is evaluating the efficacy and tolerability of carfilzomib, a selective next-generation proteasome inhibitor.
Patients who exhibited a certain genetic mutation of anti-oxidant enzymes are three times more likely to develop age-related hearing loss (ARHL), according to new research presented at the 2009 American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF) Annual Meeting & OTO EXPO, in San Diego, CA.
› Verified 9 days ago
| Entity Name | Gulf-to-bay Anesthesiology Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720039746 PECOS PAC ID: 5092628156 Enrollment ID: O20031106000250 |
News Archive
Bioject Medical Technologies Inc. (OTCBB:BJCT), a leading developer of needle-free injection therapy systems, today announced that it has established a strategic alliance with MPI Research, a leading pre-clinical research organization with experience in the development of injectable therapeutics.
"Long second shrift to other medical training, nursing education has taken on new relevance as the country faces a drastic shortage of nurses and a thin job market overall," The Dallas Morning News reports.
The fight against the deadly tropical disease Leishmaniasis, also known as black fever, has been boosted by scientists at the University of Durham, whose new screening system has raised the possibility of new, safer drugs.
Onyx Pharmaceuticals, Inc. today announced its plans to expand the Phase 3 European clinical trial FOCUS, which is evaluating the efficacy and tolerability of carfilzomib, a selective next-generation proteasome inhibitor.
Patients who exhibited a certain genetic mutation of anti-oxidant enzymes are three times more likely to develop age-related hearing loss (ARHL), according to new research presented at the 2009 American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF) Annual Meeting & OTO EXPO, in San Diego, CA.
› Verified 9 days ago
| Entity Name | Anesthesia & Pain Consultants Of Sw Fl |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609843275 PECOS PAC ID: 4082507835 Enrollment ID: O20040205000201 |
News Archive
Bioject Medical Technologies Inc. (OTCBB:BJCT), a leading developer of needle-free injection therapy systems, today announced that it has established a strategic alliance with MPI Research, a leading pre-clinical research organization with experience in the development of injectable therapeutics.
"Long second shrift to other medical training, nursing education has taken on new relevance as the country faces a drastic shortage of nurses and a thin job market overall," The Dallas Morning News reports.
The fight against the deadly tropical disease Leishmaniasis, also known as black fever, has been boosted by scientists at the University of Durham, whose new screening system has raised the possibility of new, safer drugs.
Onyx Pharmaceuticals, Inc. today announced its plans to expand the Phase 3 European clinical trial FOCUS, which is evaluating the efficacy and tolerability of carfilzomib, a selective next-generation proteasome inhibitor.
Patients who exhibited a certain genetic mutation of anti-oxidant enzymes are three times more likely to develop age-related hearing loss (ARHL), according to new research presented at the 2009 American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF) Annual Meeting & OTO EXPO, in San Diego, CA.
› Verified 9 days ago
| Entity Name | Nchmd Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831120195 PECOS PAC ID: 9436139565 Enrollment ID: O20040721000254 |
News Archive
Bioject Medical Technologies Inc. (OTCBB:BJCT), a leading developer of needle-free injection therapy systems, today announced that it has established a strategic alliance with MPI Research, a leading pre-clinical research organization with experience in the development of injectable therapeutics.
"Long second shrift to other medical training, nursing education has taken on new relevance as the country faces a drastic shortage of nurses and a thin job market overall," The Dallas Morning News reports.
The fight against the deadly tropical disease Leishmaniasis, also known as black fever, has been boosted by scientists at the University of Durham, whose new screening system has raised the possibility of new, safer drugs.
Onyx Pharmaceuticals, Inc. today announced its plans to expand the Phase 3 European clinical trial FOCUS, which is evaluating the efficacy and tolerability of carfilzomib, a selective next-generation proteasome inhibitor.
Patients who exhibited a certain genetic mutation of anti-oxidant enzymes are three times more likely to develop age-related hearing loss (ARHL), according to new research presented at the 2009 American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF) Annual Meeting & OTO EXPO, in San Diego, CA.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Adrianne N Noboa, CRNA 12511 World Plaza Ln, Building 50, Fort Myers, FL 33907-3991 Ph: (239) 939-2622 | Adrianne N Noboa, CRNA 12511 World Plaza Ln, Building 50, Fort Myers, FL 33907-3991 Ph: (239) 939-2622 |
News Archive
Bioject Medical Technologies Inc. (OTCBB:BJCT), a leading developer of needle-free injection therapy systems, today announced that it has established a strategic alliance with MPI Research, a leading pre-clinical research organization with experience in the development of injectable therapeutics.
"Long second shrift to other medical training, nursing education has taken on new relevance as the country faces a drastic shortage of nurses and a thin job market overall," The Dallas Morning News reports.
The fight against the deadly tropical disease Leishmaniasis, also known as black fever, has been boosted by scientists at the University of Durham, whose new screening system has raised the possibility of new, safer drugs.
Onyx Pharmaceuticals, Inc. today announced its plans to expand the Phase 3 European clinical trial FOCUS, which is evaluating the efficacy and tolerability of carfilzomib, a selective next-generation proteasome inhibitor.
Patients who exhibited a certain genetic mutation of anti-oxidant enzymes are three times more likely to develop age-related hearing loss (ARHL), according to new research presented at the 2009 American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF) Annual Meeting & OTO EXPO, in San Diego, CA.
› Verified 9 days ago
Kelly Alisa Zipko, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4101 Evans Ave, Fort Myers, FL 33901 Phone: 239-939-3456 Fax: 239-790-2432 | |
Ms. Jenise Lynn Wheeler, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 12511 World Plaza Ln, Fort Myers, FL 33907 Phone: 239-939-2622 | |
Miranda Klenow, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4048 Evans Ave, Ste 303, Fort Myers, FL 33901 Phone: 239-332-5344 Fax: 239-332-7246 | |
Carol M Wirth, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 115 Crescent Dr, Fort Myers, FL 33919 Phone: 239-281-6722 Fax: 239-433-9569 | |
Mrs. Natalie Hanners, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 12511 World Plaza Ln Bldg 50, Fort Myers, FL 33907 Phone: 239-939-2622 Fax: 239-939-0151 | |
Deborah Brzycki, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4048 Evans Ave, Suite 303, Fort Myers, FL 33901 Phone: 239-332-5344 Fax: 239-332-7246 | |
Candace Klein, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4048 Evans Ave, Ste 303, Fort Myers, FL 33901 Phone: 239-332-5344 Fax: 239-332-7246 |